Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sze-Huey Tan
Adoptive T-Cell Transfer and Chemotherapy in the First-Line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
Systemic Adoptive T-Cell Immunotherapy in Recurrent and Metastatic Carcinoma of the Head and Neck
Archives of Otolaryngology–Head & Neck Surgery
Treatment of Metastatic Germ Cell Tumors With Etoposide and Cisplatin as First Line Chemotherapy
Japanese Journal of Urology
Urology
Pcn190 - Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Metastatic Small Cell Carcinoma of the Prostate in an Octogenarian With Significant Response to First-Line Chemotherapy
Hematology & Medical Oncology
First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
A Systematic Review of the Clinical Effectiveness of First-Line Chemotherapy for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Thorax
Pulmonary
Respiratory Medicine
Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) Chemotherapy in the Treatment of Metastatic or Unresectable Locally Recurrent Anal Squamous Cell Carcinoma: A Phase II Study of French Interdisciplinary GERCOR and FFCD Groups (Epitopes-Hpv02 Study)
BMC Cancer
Cancer Research
Oncology
Genetics
Cost-Effectiveness Analysis of Sunitinib Versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
International Journal of Technology Assessment in Health Care
Health Policy
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology